Greatest possible health for tax money spent – central government reimbursement of medicines (RiR 2021:14)
The Swedish National Audit Office (Swedish NAO) has audited the work of the Dental and Pharmaceutical Benefits Agency (TLV) to assess which medicines will be subsidised and included in the high-cost threshold scheme. The audit also included the Government’s efforts to provide the conditions for this work. The overall conclusion of the Swedish NAO is that the Government and the TLV could do more to get the greatest possible health for the tax revenues spent by the public sector on medicines. In 2020, the cost of medicines within the pharmaceutical benefits scheme amounted to approximately SEK 34.3 billion, including patient fees.
Share in social media and by e-mail
Send your questions or comments via the form below and we will make sure that they reach the right member of staff. Please state if your question concerns the information on this particular page.